🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to assess whether abciximab is associated with...
Status
Completed
Location
Allgemeines Krankenhaus Wien
Start Date
2003-06
Trial ID
NCT00133250
Treatments Being Tested
The primary objective of this study is to investigate whether intracoronary...
Status
Unknown
Location
University Medical Centre Groningen
Start Date
2008-09
Trial ID
NCT00927615
This protocol describes a study to compare intended trans-radial versus tra...
Status
Unknown
Location
Ospedale Clinicizzato SS Annunziata di Chieti
Start Date
2011-10
Trial ID
NCT01433627
Aims: (to prove that) The distal injection of IIb IIIa platelet receptor bl...
Status
Unknown
Location
Hospital Virgen de la Salud
Start Date
2009-11
Trial ID
NCT01383785
ARC1779 is a novel drug being tested in patients undergoing angioplasty and...
Status
Terminated
Location
Archemix Investigational Site
Start Date
2007-10
Trial ID
NCT00507338
Treatments Being Tested
This study will determine the dose of Retavase that can safely be combined ...
Status
Completed
Location
Washington Hospital Center
Start Date
2002-09-24
Trial ID
NCT00046293
The purpose of this study is to determine whether abciximab given in combin...
Status
Completed
Location
Multiple Locations
Start Date
2002-08
Trial ID
NCT00046228
Treatments Being Tested
The objective of this study is to evaluate if aggressive antiplatelet thera...
Status
Completed
Location
Mount Sinai Medical Center
Start Date
2007-04
Trial ID
NCT01103440
Treatments Being Tested
The purpose of this study is to evaluate the safety and efficacy of abcixim...
Status
Completed
Location
Multiple Locations
Start Date
1993-05
Trial ID
NCT00269906
The aim of this study conducted in patients with high risk ST-segment eleva...
Status
Completed
Location
Cardiologie Hop. Duffaut
Start Date
2003-05
Trial ID
NCT00220571
Treatments Being Tested